Andrew J Walkty (Andrew Walkty)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Escherichia Coli

Cystic Fibrosis

Multidrug Resistant

Top Venues

Microbiology spectrum

Journal of clinical microbiology

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

James A Karlowsky, Andrew J Walkty, Melanie R Baxter, Heather J Adam, Philippe R S Lagacé-Wiens, Frank Schweizer, Denice C Bay, Joseph P Lynch, Michael R Mulvey, George G Zhanel
In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019. Microbiology spectrum 10 (4) (2022)
James A Karlowsky, Melanie R Baxter, Alyssa R Golden, Heather J Adam, Andrew J Walkty, Philippe R S Lagacé-Wiens, George G Zhanel
Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci. Journal of clinical microbiology 59 (12) (2021)
David A Boyd, Laura F Mataseje, Tanis Dingle, Linda Hoang, Brigitte Lefebvre, Allison McGeer, Roberto Gustavo Melano, Ian Stuart, Andrew J Walkty, Amanda Wilmer, Michael R Mulvey
Emergence of Morganellaceae Harboring bla IMP-27 Metalloenzyme in Canada. mSphere 6 (3) (2021)
Kieran A Milner, Denice C Bay, David Alexander, Andrew J Walkty, James A Karlowsky, Michael R Mulvey, Meenu K Sharma, George G Zhanel
Identification and Characterization of a Novel FosA7 Member from Fosfomycin-Resistant Escherichia coli Clinical Isolates from Canadian Hospitals. Antimicrobial agents and chemotherapy 65 (1) (2020)
Andrew J Walkty, Ali Elgheriani, Shane Silver, Peter Pieroni, John Embil
Tinea barbae presenting as a kerion. Postgraduate medical journal 96 (1137) (2020)